Ratification Date: 01/04/2025

Next Review Date: 01/04/2027

Lithium – Treatment and prophylaxis of mania, bipolar disorder, and recurrent depression; aggressive or self-mutilating behaviour

Drug Name (Brand) Lithium  (Various – prescribe branded only)
Indication Treatment and prophylaxis of mania, bipolar disorder, and recurrent depression; aggressive or self-mutilating behaviour
Traffic Light Classification ADVICE
NICE TA (plus link)  
Further Information:

NICE recommendations, summary of meeting discussions, links to additional supporting docs etc.

 

Ensure that the patient is routinely monitored for serum lithium concentration and thyroid function.

 

Prescribe by brand only.

 

 

 

 

Date of TAG recommendation / ratification 4/1/2005 Review Date 1/4/2027